HIGHLIGHTS
- who: H. Appius and collaborators from the Basel University, Basel, Switzerland have published the paper: Reproducibility of the CROSS Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Center Retrospective Observational Study, in the Journal: Journal of Oncology of 30/01/2023
- what: With this retrospective observational study the authors aimed to analyze the results of the CROSS regimen in daily practice over the last 10 years the medical records of all patients with potentially curable localized esophageal cancer (T1N1 or T2-3N0-1 M0) treated with radiochemotherapy in neoadjuvant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.